Article - 10/05/2008 Straight questions and answers The 14th Biotech Finance Forum offered selected biotechnology and medical technology companies from all over Europe the opportunity of an exclusive meeting with internationally operative investors from the venture capital VC scene. https://www.gesundheitsindustrie-bw.de/en/article/news/straight-questions-and-answers
Press release - 11/10/2012 Novalung GmbH receives EU grant for the development of a cell-coated artificial lung The AmbuLung (Ambulatory Bioartificial Lung) project is a milestone in the history of artificial organs and is being subsidized by the EU with a total of 5.6 Million Euros - 3 Million Euros will go to Novalung as the Coordinator of the European development consortium. The joint developmental goal is the AmbuLung, which will allow patients to remain awake, mobile and active despite lung failure. The core innovation within the framework of the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/novalung-gmbh-receives-eu-grant-for-the-development-of-a-cell-coated-artificial-lung
Press release - 30/04/2009 Will Ulm surgeons set new standard in bypass surgery? A new computer-assisted navigation system, developed by an interdisciplinary team of researchers and doctors at the University of Ulm over the last three years, makes bypass surgery safer and more precise.https://www.gesundheitsindustrie-bw.de/en/article/press-release/will-ulm-surgeons-set-new-standard-in-bypass-surgery
Part 2 - 06/10/2014 Expert interview: How are the prices of innovative diagnostic and medical devices determined? While there are specific regulations in Germany for the reimbursement of medicines, funding for molecular diagnostics products is complex and virtually non-existent. There is hardly any medical insurance cover for medical devices, which therefore tend to be sold on the open market. The question therefore arises as to how a reasonable price can be determined for innovative diagnostic methods and tools. In the second part of the interview conducted…https://www.gesundheitsindustrie-bw.de/en/article/news/expert-interview-how-are-the-prices-of-innovative-diagnostic-and-medical-devices-determined
Article - 06/06/2011 Knowledge transfer depends on the application of learning The ability of scientists from different disciplines to understand each other as well as excellent communication skills play an ever-increasing role in the transfer of knowledge from academic research to industry. Vice president of research at the Konstanz University of Applied Sciences HTWG Professor Gunter Voigt explains how academia and industry work together and also highlights the conditions that are necessary for such cooperations to lead…https://www.gesundheitsindustrie-bw.de/en/article/news/knowledge-transfer-depends-on-the-application-of-learning
Article - 08/06/2008 BVMed companies to found “Cataract Initiative” Companies of the German Medical Technology Association BVMed have founded the Cataract Initiative an information platform for patients and other interested parties that provides information on the benefits of modern intraocular lenses.https://www.gesundheitsindustrie-bw.de/en/article/news/bvmed-companies-to-found-cataract-initiative
Press release - 29/03/2011 Freiburg Regional Council to fund MedicalMountains cluster initiative The Freiburg Regional Council has granted MedicalMountains AG funds totalling 405,000 euros for establishing a professional management structure for the Tuttlingen-based medical technology cluster. District President Julian Würtenberger awarded the 405,000-euro grant to Dieter Teufel, president of the Schwarzwald-Baar-Heuberg Chamber of Industry and Commerce and representative of the Tuttlingen-based cluster, in which BIOPRO Baden-Württemberg…https://www.gesundheitsindustrie-bw.de/en/article/press-release/freiburg-regional-council-to-fund-medicalmountains-cluster-initiative
Article - 31/12/2012 Diagnosis of myocardial infarction: a drop of blood is all that is required Can myocardial infarction be diagnosed with a single drop of blood? The answer is yes: a new application of the ESEQuant Lateral Flow System developed by QIAGEN now makes this possible. The system, which is able to identify a broad range of bacterial and viral pathogens, including HIV, influenza virus and Chlamydia, was originally developed at the company’s site in Stockach. It has recently been adapted for use in the diagnosis of myocardial…https://www.gesundheitsindustrie-bw.de/en/article/news/diagnosis-of-myocardial-infarction-a-drop-of-blood-is-all-that-is-required
Article - 10/10/2011 Meet & Match in the BioValley – bringing together international partners Small life sciences companies find it particularly difficult to set aside time for making international contacts at trade fairs. The BioValley cluster located in a region bordered by Germany France and Switzerland has a team of scouts that focus on matchmaking. Dr. Mona Boy is the coordinator of the trinational matchmaking team of the BioValley cluster.https://www.gesundheitsindustrie-bw.de/en/article/news/meet-match-in-the-biovalley-bringing-together-international-partners
Article - 08/12/2009 Karl Stock helps turn ideas into products Karl Stock takes abstract ideas and turns them into useable technological possibilities. The 44-year-old works in what could best be described as the one-man engineering office at the Ulm-based Institute of Laser Technologies in Medicine and Metrology (ILM). In contrast to university institutes, Stock’s work does not simply finish with a “paper” published in a journal. Stock strives to go further and his real work starts where others often stop,…https://www.gesundheitsindustrie-bw.de/en/article/news/karl-stock-helps-turn-ideas-into-products
Press release - 30/09/2011 Blood Vessels from Your Printer Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn’t been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in…https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-from-your-printer
Press release - 22/02/2010 AgenoLab GmbH: Improved quality of life for patients with chronic wounds Since its foundation three years ago, AgenoLab GmbH & Co. KG in Stuttgart has become a leading service provider in the area of life sciences and biotechnology. The company’s cell culture technology unit focuses on the preparation of cells that can largely eliminate the need for animal testing. In the area of regenerative medicine, AgenoLab GmbH concentrates on the growth of skin cells as transplants for patients suffering from burns and…https://www.gesundheitsindustrie-bw.de/en/article/press-release/agenolab-gmbh-improved-quality-of-life-for-patients-with-chronic-wounds
Press release - 14/07/2009 Amedrix GmbH - Successful cell-free products The cell biologist Dr. Thomas Graeve has founded Amedrix GmbH in Esslingen. In future, the company will develop and produce innovative, cell-free medical products based on animal collagen for the purpose of wound regeneration and the reconstruction of degenerated soft tissue, for example. https://www.gesundheitsindustrie-bw.de/en/article/press-release/amedrix-gmbh-successful-cell-free-products
Press release - 02/09/2011 German Government starts the initiative "Health - Made in Germany" The overall aim of the initiative is to exploit the dormant capacities that lie within the export of health care products made in Germany. In Germany, many companies are already world leaders in their fields, in part due to a policy of consistent and early promotion of health care in Germany. German technology suppliers possess decades of valuable experience in realizing health care projects both at home and abroad. Provider of products and…https://www.gesundheitsindustrie-bw.de/en/article/press-release/german-government-starts-the-initiative-health-made-in-germany
Press release - 08/03/2010 Innovative microsystems – injection-moulded and printed Up-to-date injection moulding and printing methods can now be used to produce microtechnical components and entire functional units inexpensively and with the highest possible precision. Refined processing, coating and manufacturing techniques can make the serial production of microsystems considerably easier. Moreover, microsensors are increasingly being used as multifunctional units in the automotive, laboratory, medical and automation…https://www.gesundheitsindustrie-bw.de/en/article/press-release/innovative-microsystems-injection-moulded-and-printed
Press release - 27/10/2009 Precision Diagnosis of Brain Tumors: Antibody to Detect Enzyme Defect More than 100 different types of brain tumor are known in medicine. Their exact diagnosis is often difficult, because only tiny amounts of tumor tissue are usually available. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the University of Heidelberg have developed an antibody which is highly specific for the characteristic alteration of an enzyme that is typical of two dangerous types of brain tumor.…https://www.gesundheitsindustrie-bw.de/en/article/press-release/precision-diagnosis-of-brain-tumors-antibody-to-detect-enzyme-defect
Article - 14/01/2008 Tetec AG to erect new building in Reutlingen Tetec AG a leader in regenerative medicine is building a new facility in ReutlingenKusterdingen in which Aesculap AG is the only investor. This construction represents a major progress for the Medical technology and health TuttlingenNeckar-Alb top cluster. https://www.gesundheitsindustrie-bw.de/en/article/news/tetec-ag-to-erect-new-building-in-reutlingen
Press release - 06/01/2008 20 years of pharmaceutical technology The Albstadt-Sigmaringen University of Applied Sciences was the first to offer a pharmaceutical technology course back in 19871988. The course has become a great success and the graduates are sought after in both the pharmaceutical and medical technology industries.https://www.gesundheitsindustrie-bw.de/en/article/press-release/20-years-of-pharmaceutical-technology
Article - 03/04/2019 HKK Bionics empowers hand gripping functions A spin-off from the Ulm University of Applied Sciences is aiming to provide people whose hands have been paralysed due to accident or illness with a new kind of orthopaedic aid. Dominik Hepp and Tobias Knobloch are currently starting serial production of a hand orthosis prototype. The two medical engineers from Ulm, who founded HKK Bionics GmbH in 2017, plan to commence final tests in 2019.https://www.gesundheitsindustrie-bw.de/en/article/news/hkk-bionics-empowers-hand-gripping-functions
Dossier - 04/07/2011 Implants of the future: bioactive, corrosion-resistant and antibacterial People’s life expectancy is increasing due to constantly improving medical treatment. One result of this is the greater wear of joints, which then need to be replaced with implants. Increased life expectancy means that the implants remain in the body for much longer and therefore need to be longer lasting. The revision rate of implant materials used in clinical practice is still as much as 10 per cent, particularly in the case of hip and knee…https://www.gesundheitsindustrie-bw.de/en/article/dossier/implants-of-the-future-bioactive-corrosion-resistant-and-antibacterial
Press release - 07/03/2011 Review: MicroMountains Innovation Forum 2011: Networking - Motor for Innovation The third MicroMountains Innovation Forum, held in Villingen-Schwenningen on 2nd February 2011, focused exclusively on microtechnologies. In cooperation with the local Chamber of Commerce and Industry, the MicroMountains network provided around 160 participants with insights into the application of microtechnologies in the fields of medical, measurement and automotive technologies as well as giving them the opportunity to exchange experiences. https://www.gesundheitsindustrie-bw.de/en/article/press-release/review-micromountains-innovation-forum-2011-networking-motor-for-innovation
Press release - 07/11/2011 Third quarter: HARTMANN increases sales in all business segments The HARTMANN GROUP continued its growth despite the difficult conditions in the health markets. Global sales revenues increased by 5.0 percent to EUR 1,263.8 million compared to the previous year.https://www.gesundheitsindustrie-bw.de/en/article/press-release/third-quarter-hartmann-increases-sales-in-all-business-segments
Article - 01/08/2008 Many doctors, one patient file Patients will often see several doctors. Computer scientists at the Centre for Information and Medical Technology at the University of Heidelberg are developing a new electronic patient file to enable the smooth transfer of patient data.https://www.gesundheitsindustrie-bw.de/en/article/news/many-doctors-one-patient-file
Overview Pharmaceutics The latest articles, press releases and dossiers on pharmaceutics in Baden-Württemberghttps://www.gesundheitsindustrie-bw.de/en/article/pharma
Press release - 16/11/2015 The Baden-Württemberg healthcare industry – a strong economic power (Stuttgart – 16th November 2015) BIOPRO Baden-Württemberg has just published its latest analysis of the Baden-Württemberg healthcare industry including comprehensive facts and figures. Baden-Württemberg continues to be one of the top locations for medical technology, pharma and biotechnology in Germany. https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-baden-wuerttemberg-healthcare-industry-a-strong-economic-power